Colorectal cancer patients whose disease exhibits certain rare genetic signatures have the option of treatment with immunotherapies. But these targeted cancer treatments haven’t worked for patients ...
– Collaboration leverages Cartography’s cutting-edge ATLAS and SUMMIT platforms to identify tumor-selective antigens; Pfizer to lead therapeutic development – – Cartography to receive upfront, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results